Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Participants who enter the study and are already taking insulin glargine with a screening HbA1c \>7.0% will be randomized to one of two treatment arms. Both arms will add prandial insulin to existing basal insulin therapy.